AI Generated Image
What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug
CBS News • • health
Key Points:
- Experimental weight-loss drug retatrutide, not approved by the FDA, is being sold openly in Brooklyn bodegas like Mr. Green without prescriptions or age verification, despite federal laws prohibiting such sales.
- The peptide vendor Indr Labs, whose products are labeled "for research use only," has been linked to fake lab certificates and questionable product authenticity, raising concerns about the safety and legitimacy of the drugs sold.
- Medical experts and regulatory authorities express alarm at the brazen retail marketing of retatrutide, with some calling for stronger enforcement against illicit sales and highlighting potential health risks from unregulated use.
- Eli Lilly, the developer of retatrutide, urges law enforcement to dismantle black-market networks, as social media buzz has fueled demand for the drug well ahead of FDA approval.
- Reports of adverse effects and toxicities related to retatrutide are increasing, with poison control centers and the FDA receiving more unverified claims, underscoring the dangers of unsupervised use of experimental drugs.
